ManRos Therapeutics looks forward to see you at the “Palais du Grand Large” in Saint-Malo, France, from March 28th to April 1st 2017. Over 50 speakers will present the progress of their research work on the DYRK1A kinase, involved in Alzheimer’s disease and Down syndrome.